10.1371/journal.pone.0202575.g002
Sasha Gulati
Sasha
Gulati
Ole Solheim
Ole
Solheim
Sven M. Carlsen
Sven
M. Carlsen
Lise R. Øie
Lise R.
Øie
Heidi Jensberg
Heidi
Jensberg
Agnete M. Gulati
Agnete M.
Gulati
Mattis A. Madsbu
Mattis A.
Madsbu
Charalampis Giannadakis
Charalampis
Giannadakis
Asgeir S. Jakola
Asgeir
S. Jakola
Øyvind Salvesen
Øyvind
Salvesen
Survival following ICH in users and non-users of antithrombotic medications.
Public Library of Science
2018
Norwegian Prescription Database
antithrombotic medication
clopidogrel
antithrombotic medication safety
RICH
incidence rates
HR
aspirin
CI
Nationwide pharmacoepidemiological study Background
Annual crude ICH rates
antithrombotic drugs
antithrombotic medication regimens
warfarin
user
Norwegian Patient Registry
NCT
2018-08-23 17:57:06
Figure
https://plos.figshare.com/articles/figure/Survival_following_ICH_in_users_and_non-users_of_antithrombotic_medications_/7004048
<p>There were significant differences in survival following ICH and in all four subgroups hemorrhagic stroke, subdural hemorrhage, subarachnoid hemorrhage, and traumatic intracranial hemorrhage between users and non-users of antithrombotic medications (all p<0.001). The shaded areas indicate 95% CIs. (A) Survival following any intracranial hemorrhage. (B) Survival following hemorrhagic stroke. (C) Survival following subdural hemorrhage. (D) Survival following subarachnoid hemorrhage. (E) Survival following traumatic intracranial hemorrhage.</p>